Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Stephan Madersbacher"'
Publikováno v:
Expert Opinion on Drug Safety. 18:915-923
Introduction: Muscarinic receptor antagonists, 5α-reductase inhibitors and α1-adrenoceptor antagonists are frequently used drug classes for the treatment of lower urinary tract symptoms including those of overactive bladder syndrome and benign pros